Aevice Health
Aevice Health offers wearable devices for remote monitoring of respiratory conditions.
- Company typePrivate
- Founded2016
- HeadquartersSingapore, Singapore
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aevice Health does
Aevice Health provides non-invasive wearable technology that enables real-time monitoring of respiratory health. The devices facilitate early detection of cardiopulmonary issues and allow clinicians to track patient responses to treatment effectively. This approach enhances patient care by delivering critical insights directly from home.
Aevice Health firmographics
Firmographics- Name
- Aevice Health
- Legal name
- Aevice Health Pte Ltd
- Website
- https://www.aevice.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Aevice Health offers wearable devices for remote monitoring of respiratory conditions.
- Ownership category
- akta.pro rank
Aevice Health industry classification
Industry- Product category
- Remote Patient Monitoring Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
- akta.pro secondary industries
- Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)
Keywords
Where Aevice Health is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices1 record
Markets served
Aevice Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Hardware Sales (AeviceMD Device): Sale of the AeviceMD wearable stethoscope device to healthcare providers, hospitals, and clinics. The device is provided to patients through healthcare provider programs, not sold directly to patients.
- Remote Patient Monitoring Services: Subscription-based remote patient monitoring platform enabling continuous respiratory monitoring, data analytics, and clinician dashboard access for chronic respiratory disease management.
- Healthcare Provider Partnerships: Partnerships with healthcare providers like Parkway MediCentre for pediatric asthma monitoring programs. Device made available to eligible patients through pediatrician supervision.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Healthcare Provider Program |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Aevice Health product offering
Product offeringCore offering
Aevice Health develops and sells the AeviceMD Monitoring System, a Class II medical device comprising a small wearable smart stethoscope sensor, a patient mobile app, and a healthcare provider web portal. The system continuously monitors lung sounds, detects wheezing, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations, supporting chronic respiratory disease management for patients aged 3 and above.
Product overview
Aevice Health offers the AeviceMD Monitoring System, a unified remote respiratory care platform combining a wearable smart stethoscope sensor with patient mobile app and healthcare provider web portal modules. The flagship AeviceMD wearable sensor serves as the core data collection device, capturing continuous lung sounds, wheeze detection, heart rate, and respiratory rate. The patient mobile app enables medication tracking, real-time monitoring, and remote auscultation sharing. The provider web portal delivers patient management with risk-scored profiles, vital signs dashboards, and telehealth facilitation capabilities. Whitepapers on Virtual Asthma Care and Digital Auscultation support implementation and clinical adoption.
Differentiator
Problem solved
Functional benefit
Brands
- AeviceMD: Flagship smart wearable stethoscope and remote patient monitoring platform for chronic respiratory disease management, featuring wheeze detection, heart rate monitoring, respiratory rate measurement, and digital auscultation.
Products and services
- AeviceMD Monitoring System Comprehensive remote patient monitoring platform for chronic respiratory disease management, combining a wearable smart stethoscope sensor, patient mobile app, and healthcare provider web portal. Continuously monitors lung sounds, detects wheeze, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations for patients aged 3 and above.
- AeviceMD Wearable Sensor The world's smallest wearable smart stethoscope (9 grams, 1.2 inches diameter) that attaches to the chest via silicone patch for non-invasive continuous monitoring of cardiopulmonary sounds during sleep and daily activities. FDA 510(k) cleared, HSA approved in Singapore, and TGA certified in Australia.
Quantifiable outcome
- 47% decrease in likelihood of asthma attacks in patients with good management of their condition
- +3 more outcomes
Companies that use Aevice Health
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles1 record
Aevice Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Aevice Health partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, flagship and minor.
- Parkway MediCentrecoreHome-based paediatric asthma monitoring programme partnership. AeviceMD integrated into paediatric care pathways. Available at Parkway MediCentre @ The Woodleigh Mall. Part of IHH Healthcare Singapore's ambulatory care network.
- Jiva.aicoreCo-innovation programme funded by Innovate UK and Enterprise Singapore to develop AI-powered asthma exacerbation prediction. Combined AeviceMD with Jiva.ai's model-fusion AI platform. Achieved over 60% prediction accuracy across 24, 48, and 72-hour windows using data from 185 patients.
- Cedars-SinaiflagshipClinical collaboration through Cedars-Sinai Accelerator Class 8 program. Mentorship from clinical key opinion leaders, executive management, operations members. Pilot program with Cedars-Sinai Medical Center.
- National University Health System (NUHS)coreClinical study at National University Hospital (NUH) to validate AeviceMD in detecting lung sound abnormalities in paediatric patients. Coordinated through NUHS Centre for Innovation in Healthcare (CIH).
- Toho HoldingscoreStrategic collaboration to expand into Japan market. Toho Holdings operates over 700 pharmacies across Japan. Joint development and commercialization of AeviceMD for Japanese patients with chronic respiratory diseases.
- THB GlobalminorPartnership to advance remote monitoring of chronic respiratory diseases in MENASA region (Middle East, North Africa, and South Asia). THB Global has offices in Singapore, Dubai, and Karachi.
- A*STAR SingaporecoreResearch collaboration to develop predictive model for asthma attack among children using continuous measures from wearable device. Supported by HealthTEC Singapore seed grant.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Aevice Health competitors and assessment
Company assessmentBroad incumbents
- ResMed: Global leader in sleep and respiratory care devices, with a growing connected health portfolio including Propeller Health for respiratory RPM. Comparable as a respiratory-focused medtech with continuous-monitoring hardware, software platform, and recurring revenue model; substantially larger and more established than Aevice.
- Philips (Connected Care / RPM): Diversified medtech incumbent with a broad RPM and hospital monitoring portfolio (including biosensor-based RPM via its acquisition of BioTelemetry). Comparable as a large-scale provider of respiratory and chronic disease RPM solutions to hospitals and health systems.
Direct peers
- Propeller Health (ResMed): Digital respiratory health platform (acquired by ResMed) offering connected inhalers and RPM software for asthma and COPD. Directly comparable as an asthma/COPD remote monitoring solution targeting the same patient populations and healthcare provider buyers that Aevice serves.
- Eko Health: Developer of AI-powered digital stethoscopes and cardiopulmonary auscultation software for clinicians. Directly comparable as an AI-augmented smart stethoscope company with FDA-cleared devices, AI-driven lung/heart sound analysis, and telehealth integration - a parallel product category to AeviceMD.
- StethoMe: Poland-based digital health company offering an AI-powered electronic stethoscope for remote respiratory monitoring, with CE-marked pediatric and adult solutions. Closely comparable to Aevice as a smart stethoscope with wheeze/asthma detection targeting home monitoring and pediatric care.
- Tytocare: Provider of a remote medical examination device that captures heart and lung sounds for teleconsultation. Comparable as a remote auscultation and virtual care platform enabling clinicians to assess patients at home, overlapping with Aevice's teleconsultation use cases.
- Current Health (Best Buy Health): Acquired by Best Buy Health, Current Health provides a wearable RPM platform for continuous vital sign monitoring at home, including respiratory rate. Comparable as a wearable-based RPM solution for chronic disease management targeting hospital and health system customers.
- Biofourmis: AI-driven RPM platform combining wearable biosensors with predictive analytics for chronic and acute condition management, with respiratory applications. Comparable as a device-plus-AI RPM platform sold to health systems and providers, with a subscription/enterprise model similar to Aevice's.
Emerging players
- Sonavi Labs: Developer of an AI-powered digital stethoscope (Feelix) for respiratory disease detection and remote monitoring. Comparable as an emerging smart-stethoscope player focused on automated lung sound analysis and telehealth enablement, with similar early-stage scale to Aevice.
- VitalConnect: Provider of wearable biosensor patches (VitalPatch) for continuous cardiac and respiratory monitoring in hospital and home settings. Comparable as a wearable, FDA-cleared continuous-monitoring patch company with a hospital-focused GTM motion.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Aevice Health social profiles
Digital presenceAevice Health compliance and trust
Trust signalCompliance5 records
Aevice Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aevice Health leadership team
Management profileNumber of profiles
Profiles5 records
Aevice Health funding detail
Funding detailFunding overview
Funding rounds10 records
Investors14 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aevice Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aevice Health
What does Aevice Health do?
Aevice Health develops and sells the AeviceMD Monitoring System, a Class II medical device comprising a small wearable smart stethoscope sensor, a patient mobile app, and a healthcare provider web portal. The system continuously monitors lung sounds, detects wheezing, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations, supporting chronic respiratory disease management for patients aged 3 and above.
Is Aevice Health a public or private company?
Aevice Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aevice Health founded?
Aevice Health was founded in 2016. It employs 11 to 50 people.
Where is Aevice Health based?
Aevice Health is headquartered in Singapore, Singapore, in the Asia region.
How does Aevice Health make money?
Three revenue lines are on record. Hardware Sales (AeviceMD Device) is the primary driver. The others are remote Patient Monitoring Services and healthcare Provider Partnerships.
Who are Aevice Health's main competitors?
Broad incumbents on record are ResMed and Philips (Connected Care / RPM). Direct peers are Propeller Health (ResMed), Eko Health, StethoMe, Tytocare, Current Health (Best Buy Health) and Biofourmis. Emerging players are Sonavi Labs and VitalConnect.
Does Aevice Health have an API?
No public API is recorded for Aevice Health.
What industry is Aevice Health in?
Aevice Health's product category is Remote Patient Monitoring Medical Devices. Its primary akta.pro industry code is HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate), with a secondary code of HLACAPAD, Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension). Its NAICS code is 334510 and its SIC code is 3845.